Stock Events

Stock Events

Aton

€0.02

18

-€0-21.9% Today

Statistics

Day High

0.02

Day Low

0.02

52W High

0.02

52W Low

0

Volume

0

Avg. Volume

-

Mkt Cap

13.38M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

13MarExpected

Q3 2017

Q1 2024

Q2 2024

Q4 2024

Q4 2025

-0.17

0.16

0.5

0.83

Expected EPS

N/A

Actual EPS

N/A

Financials

-179.32%Profit Margin

Unprofitable

2019

2020

2021

2022

2023

2024

1.23MRevenue

-2.2MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 3HB.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Amgen is a biotechnology company that competes in developing innovative therapies, similar to Hybrigenics' focus on cancer and other diseases.

Gilead Sciences

Gilead Sciences is involved in the research and development of therapeutic products in areas like oncology, competing directly with Hybrigenics' cancer treatment efforts.

Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company with a strong emphasis on cancer research and treatments, directly competing with Hybrigenics.

Pfizer is a global pharmaceutical company with a broad range of products, including in oncology, making it a competitor to Hybrigenics.

Merck & Co. focuses on cancer drugs and vaccines, which puts it in direct competition with Hybrigenics in the oncology sector.

Novartis is a global healthcare company that has a significant presence in the oncology market, competing with Hybrigenics.

Roche Holding AG is a leader in oncology, directly competing with Hybrigenics in the development of cancer treatments.

AstraZeneca is a biopharmaceutical company focusing on the discovery, development, and commercialization of prescription medicines, including for cancer, making it a competitor to Hybrigenics.

Sanofi is a global healthcare leader that offers treatments in oncology, competing with Hybrigenics in the cancer treatment space.

Eli Lilly and Company is a global pharmaceutical company that has a focus on oncology, competing with Hybrigenics in developing cancer treatments.

About

Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.

Show more...

CEO

Country

France

ISIN

FR0004153930

WKN

000A0M9ZU

Listings

0 Comments

Share your thoughts

FAQ

What is Aton stock price today?▼

The current price of 3HB.F is €0.02 EUR — it has decreased by -21.9% in the past 24 hours. Watch Aton stock price performance more closely on the chart.

What is Aton stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Aton stocks are traded under the ticker 3HB.F.

Is Aton stock price growing?▼

3HB.F stock has risen by +530.77% compared to the previous week, the month change is a +485.71% rise, over the last year Aton has showed a +177.97% increase.

What is Aton market cap?▼

Today Aton has the market capitalization of 13.38M

What is Aton revenue for the last year?▼

Aton revenue for the last year amounts to 1.23M EUR.

What is Aton net income for the last year?▼

3HB.F net income for the last year is -2.2M EUR.

In which sector is Aton located?▼

Aton operates in the Materials sector.

When did Aton complete a stock split?▼

The last stock split for Aton was on September 06, 2023 with a ratio of 5:1.